Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check2 days agoChange DetectedA site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe study page was updated to revision v3.7.0, and several sections such as plain-language trial summary, results, sponsor references, and related regulatory/ keywords were removed from the listing. This changes how the study is presented and navigated.SummaryDifference21%

- Check58 days agoChange DetectedThe NIH grant/contract year 2016 is added to the study details, and the page revision is updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision tag was updated to v3.6.5, replacing v3.6.4. This appears to be a maintenance/version update rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.